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Background
Colorectal cancer (CRC) is the 3rd most common
cancer in Canada, often occurring at older ages. While
early-onset CRC can be suggestive of an inherited
syndrome, the underlying genetic cause remains unex-
plained in many of these young individuals.
Method
Clinicopathologic features along with genetic and family
information were collected on individuals diagnosed
with CRC ≤35 years old identified through the Familial
Gastrointestinal Cancer Registry in Toronto, Canada.
Results
441 individuals from 353 families were identified, and
to-date, medical records confirmed 254 diagnoses,
which were included for analysis. Ninety patients
(35.4%) had germline mutations in self or kin (31
MSH2, 36 MLHI, 1 MSH6, 3 PMS2, 24 APC, 2 MYH
biallelic and 1 BRCA2). Individuals were classified into
six categories; (a) 74 had Lynch syndrome (LS) con-
firmed by germline mutation or tumour deficiency (b)
4 had constitutional mismatch repair-deficiency
(CMMR-D) (c) 61 had polyposis (mutation positive,
>25 adenomas or hamartomatous polyps), (d) 6 met
Family X criteria, (e) 7 had inflammatory bowel disease
(IBD), and (f) 102 were unclassified (NOS), with 69 of
these individuals having MSS and/or IHC intact
tumours.
On average, patients with CMMR-D presented
younger, with a mean age of 14 years old at diagnosis.
65.2% of patients with LS presented with a proximal
tumour (65.2%) compared with the polyposis (10.2%)
and NOS (34.4%) groups. In contrast, 83% of polyposis
patients and 65.5% of NOS patients presented with dis-
tal colon or rectal cancers.
Family history was significant for the majority of LS
patients with 54 of 73 (74%) meeting Amsterdam I or II
criteria. Two of the 7 patients with IBD, and 15 of 98
NOS patients also met Amsterdam I/II criteria, as
opposed to the CMMR-D families where none met
these criteria. Six LS patients presented with sporadic
CRC, as did approximately 25% of polyposis patients
and 59.2% of the NOS patients.
Conclusions
Cancer site differs between individuals ≤35 years with
LS, polyposis and NOS CRC. Greater than 1/3 of
patients presented with no significant family history of
CRC. While the majority of patients diagnosed with
CRC ≤35 have a known hereditary CRC syndrome or
risk predisposition, 69 of 221 (31.2%) of individuals
appear to have no recognizable syndrome.
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